Hormone therapy and phytoestrogens

Journal of Clinical Pharmacy and Therapeutics

Volumn 21, Issue 2, 1996, Pages 101-111

  Lien, L L ^a   Lien, E J ^b  

^a USC School of Pharmacy ^*  (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE; PHYTOESTROGEN; VITAMIN D;

ARTICLE; CALCIUM INTAKE; CARDIOVASCULAR DISEASE; CHINESE MEDICINE; DRUG CONTRAINDICATION; DRUG EFFECT; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; EXERCISE; HUMAN; LIPID BLOOD LEVEL; MASTALGIA; POSTMENOPAUSE OSTEOPOROSIS; VAGINA BLEEDING;

EID: 0029954717     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2710.1996.tb00008.x     Document Type: Article

References (27)

1. Rodgers K. (1994) Consistent hormone levels, low abuse: testoderm patch. Drug Topics, 138(12), 26.
2. Symons A. (1994) Changing therapy for change of life. Drug Store News, 4(10) S25.
3. Das A, Wang JH, Lien EJ. (1994) Carcinogenicity, mutagenicity and cancer preventing activities of flavonoids: a structure-system-activity relationship (SSAR) analysis. Progress in Drug Research, 42, 133-166.
4. Das A, Lien EJ. (1994) Estrogenic activity of isoflavonoids and coumestrol. Pharmaceutical Research, 11, S118.
5. Alexander W. (1992) More women could benefit from hormone replacement, reports suggest. American Pharmacy, NS32(8), 56-60.
6. Prince RL, Smith M, Dick IM, et al. (1991) Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy. The New England Journal of Medicine, 325(17), 1189-1195.
7. Grollman A, Grollman EF. (1970) Pharmacology and Therapeutics, pp. 801. Lea & Febiger, Philadelphia, U.S.A.
8. Riffee JM. (1992) Osteoporosis: Prevention and management. American Pharmacy, NS32(8), 61-71.
9. Gebara OCE, Mittleman MA, Sutherland P, et al. (1995) Association between increased estrogen status and increased fibrinolytic potential in the Framingham offspring study. Circulation, 91, 1952-1958.
10. Calle EE, Miracle-McMahill HL, et al. (1995) Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. Journal of the National Cancer Institute, 87, 517-523.
11. Rodriguez C, et al. (1995) Estrogen replacement therapy and fatal ovarian cancer. American Journal of Epidemiology, 141, 825-835.
12. Sifton DW. (1994) Physicians' Desk Reference. 48th edn, pp. 438-2303. Medical Economics Data Production Co., Montvale, NJ, U.S.A.
13. Aloia JF, Vaswani A, Yeh JK, et al. (1994) Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Annals Internal Medicine, 120, 97-103.
14. Bays HE, Dujovne CA. (1994) Drugs for treatment of patients with high cholesterol blood levels and other dyslipidemia. Progress in Drug Research, 43, 19-36.
15. Crook D, Cust MP, Gangar KF, et al. (1992) Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins. American Journal of Obstetrics and Gynecology, 166, 950-955.
16. Anon. (1995) FDA approves hormone replacement medications. An official publication of the American Pharmaceutical Association, Pharmacy Today,1(2), 2.
17. Anon. (1994) Combination hormone therapy benefits cited. Pharmacy Times, 60(12), 2-4.
18. Biro S. (1995) Education, early detection best defense against breast cancer; pharmacist play crucial role. An official publication of the American Pharmaceutical Association. Pharmacy Today, 1(2), 7.
19. Anon. (1994) Estrogens potentiate the occurrence of thrombophlebitis. Drug Store News, 4(12), 64-65.
20. McGuinness ME, Talbert RL. (1994) Management of thyroid disorders. American Pharmacy, NS34(12), 36-47.
21. Nichols WK. (1995) Hormones. In: Remington: The Science and Practice of Pharmacy, ed Gennaro, 19th edn, p. 1089. Mack Publishing Co. Easton.
22. Chiang Su New Medical College. (1979) Chon Yao Da Tze Dian, pp. 181-2677, Shanghai Science Technology Publisher, Shanghai, China.
23. Hsu HY, Chou YP, Hong M. (1982) The Chemical Constituents of Oriental Herbs, Oriental Healing Arts Institute, Long Beach, CA, U.S.A.
24. Hsu HY, Easer DH. (1982) For Women Only: Chinese Herbal Formulas, pp. 73-77. Oriental Healing Arts Institute, Long Beach, CA, U.S.A.
25. Lien EJ, Gao H, Hsu CS, et al. (1992) Longevity promoting agents: a survey. International Journal of Oriental Medicine, 17, 177-186.
26. Liener IE. (1980) Estrogenic factors. In: Toxic Constituents of Plant Foodstuffs, pp.430-432. Academic Press, New York, U.S.A.
27. Mowrey DB. (1986) The Scientific Validation of Herbal Medicine, pp. 2-279. Keats Publishing Inc., New Canaan, Connecticut, U.S.A.